Travere therapeutics announces completion of public offering of common stock and exercise in full of underwriters' option to purchase additional shares

San diego, feb. 17, 2021 (globe newswire) -- travere therapeutics, inc. (nasdaq: tvtx) today announced the completion of its previously announced underwritten public offering of 7,532,500 shares of its common stock at a price to the public of $26.75 per share, including 982,500 shares sold pursuant to the exercise in full of the underwriters' option to purchase additional shares. all of the shares were sold by travere. including the option exercise, the aggregate gross proceeds from the offering were approximately $201.5 million, before deducting the underwriting discounts and commissions and offering expenses.
TVTX Ratings Summary
TVTX Quant Ranking